The content of CpG-DNA in antigen-CpG conjugate vaccines determines their cross-presentation activity
RM Clauson, B Berg, B Chertok - Bioconjugate Chemistry, 2019 - ACS Publications
Cross-presentation, the process that facilitates display of exogenous antigens on MHC-I
molecules, is a crucial step in the cascade of CD8 T cell activation. Potentiation of cross …
molecules, is a crucial step in the cascade of CD8 T cell activation. Potentiation of cross …
The Content of CpG-DNA in Antigen-CpG Conjugate Vaccines Determines Their Cross-Presentation Activity.
RM Clauson, B Berg, B Chertok - Bioconjugate Chemistry, 2019 - europepmc.org
Cross-presentation, the process that facilitates display of exogenous antigens on MHC-I
molecules, is a crucial step in the cascade of CD8 T cell activation. Potentiation of cross …
molecules, is a crucial step in the cascade of CD8 T cell activation. Potentiation of cross …
The Content of CpG-DNA in Antigen-CpG Conjugate Vaccines Determines Their Cross-Presentation Activity
RM Clauson, B Berg, B Chertok - Bioconjugate Chemistry, 2019 - Elsevier
Cross-presentation, the process that facilitates display of exogenous antigens on MHC-I
molecules, is a crucial step in the cascade of CD8 T cell activation. Potentiation of cross …
molecules, is a crucial step in the cascade of CD8 T cell activation. Potentiation of cross …
The Content of CpG-DNA in Antigen-CpG Conjugate Vaccines Determines Their Cross-Presentation Activity
RM Clauson, B Berg, B Chertok - Bioconjugate chemistry, 2019 - pubmed.ncbi.nlm.nih.gov
Cross-presentation, the process that facilitates display of exogenous antigens on MHC-I
molecules, is a crucial step in the cascade of CD8 T cell activation. Potentiation of cross …
molecules, is a crucial step in the cascade of CD8 T cell activation. Potentiation of cross …